(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO LIGANTE, COMPOSTO FÁRMACO-LIGANTE, CONJUGADO, COMPOSIÇÃO FARMACÊUTICA, MÉTODO PARA TRATAR UM INDIVÍDUO, E, GRUPO POLAR

Em AnáliseInvention PatentPCT · US2024011307

Application data

Number

112025014310

Type

Invention Patent

Filing

01/11/2024

Publication

03/31/2026

PCT

US2024011307

Progress at the INPI

Examination not yet requested
  1. Filing01/11/24
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 01/11/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:01/11/2027(139 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/31/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GENMAB A/S

DK

See this company's full portfolio

Inventors

G. W. (pessoa física)

CN

H. L. (pessoa física)

CN

X. J. (pessoa física)

CN

X. S. (pessoa física)

US

Technical data

Priority claims

CN

PCT/CN2023/071781 · 01/11/2023

Abstract

COMPOSTO LIGANTE, COMPOSTO FÁRMACO-LIGANTE, CONJUGADO, COMPOSIÇÃO FARMACÊUTICA, MÉTODO PARA TRATAR UM INDIVÍDUO, E, GRUPO POLAR. Modalidades da presente invenção provêm grupos Polares, compostos ligantes, Fármacos-Ligantes e seus conjugados.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/31/2026

RPI 2882

Alteração de dados cadastrais

#1.1

07/22/2025

RPI 2846

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.